Distomatose Des Voies Biliaires. Interet De La Cholangiography Retrograde. Efficacite Du Triclabendazole.

References

• Ambroise-Thomas P, Goullier A, Peyron F. Les distomatoses. Encycl. Med. Chir. (Paris, France), Maladies infectieuses, 8110 A10, 4–1986, 10 p.
   Google Scholar
• Bugnon P, Portier H, Cudey B, Collin P, Kapelli JP, d’Athis R: ActualitSs de la distomatose. Med Mai Infect. 1984; 14: 16–24.
   Google Scholar
• Ripert C, Tribouley J, Luong Dinh Giap G, Combe A, Laborde M, Bourianne C. Epidemiologic de la fasciolase humaine dans le sud-ouest de la France. Med Chir Dig. 1988: 17: 355–8.
   Google Scholar
• Chicco J, Gallais H. La distomatose h6patique. A propos de 3 observations familiales. Medit Med. 1975;3:49–86.
   Google Scholar
• Modavi S, Isserf H. Fasciola hepatica: Collagen deposition and other histopathology in the rat host’s bile duct caused by the parasite and by proline infusion. Exper Parasitol. 1984; 58: 23944.
   Google Scholar
• Schussele A, Laperrouza C. Les distomatoses hepatiques: a propos de 9 observations personnelles. Schweiz Med Wschr. 1971; 101: 1677–87.
   Google Scholar
• Bonniaud P, Barthelemy C, Veyret C, Audigier JC, Fraisse H. Aspect ultrasonore de la distomatose des voies biliaires. J Radiol. 1984; 65: 589–91.
   Google Scholar
• Camara BM, Cicero FG, Sahel J: Distomatoses des voies biliaires, interet de I’echotomographie. MedTrop. 1987; 47: 189–92.
   Google Scholar
• Houry S, Younes P, Huguier M. Distomatose de la vesicule biliaire. Aspect echographique. J Radiol. 1983; 64: 353–4.
   Google Scholar
• Van Beers B, Pringot J, Geubel A, Trigaux JP, BigaignonG, Dooms G. Hepatobiliary fasciolasis: noninvasive imaging findings. Radiology. 1990; 174: 809–10.
   Google Scholar
• TakeyamaN, Okumura N, Sakai Y et al. Computed tomography findings of hepatic lesions in human fasciolasis: report of two cases. Am J Gastroenterol. 1986; 81: 1078–81.
   Google Scholar
• Condomines J, Rene-Espinet JM, Espinos-Perez JC, Vilardell F. Percutaneous cholangiography in the diagnosis of hepatic fasciolasis. Am J Gastroenterol. 1985; 80: 384–6.
   Google Scholar
• Wong RKH, Peura DA, Mutter ML, Heit HA, Birns MT, Johnson LF. Hemobilia and liver flukes in a patient from Thailand. Gastroenterology. 1986; 88: 1958–63.
   Google Scholar
• Farag HF, Ragab M, Salem A, Sadek N. A short note on praziquantel in human fasciolasis. J Trop MedHyg. 1986; 89:79–80.
   Google Scholar
• Farid Z, Trabolsi B, Boctor F, Hafez A. Unsuccessful use of praziquantel to treat acute fasciolasis in children. J Infect Dis. 1986; 154:920–1.
   Google Scholar
• Knobloch J, Delgado E, Alvarez OA, Reymann U, Bialek R. Human fasciolasis in Cajamarca/Peru. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol. 1985; 36: 88–90.
   Google Scholar
• Schiappacasse RH, Mohammadi D, Christie AJ. Successful treatment of severe infection with Fasciola hepatica with praziquantel. J Infect Dis. 1985; 152: 1339–40.
   Google Scholar
• DugernierT, Geubel A, Bigaignon G, Cesbron JY, Coche E. Human fasciolasis: cure by mebendazole? A case report. Gastroenterol Clin Biol. 1986; 10: 513–6.
   Google Scholar
• Bourgeade A. Distomatoses. In: Traitement des maladies infectieuses, Ed. Bertrand A, Flammarion M6decine-Sciences, Paris, 1981, 353–5.
   Google Scholar
• Nik-Akhtar B, Tabibi V. Metronidazole in fasciolasis. Report of four cases. N Engl J Med. 1977; 297: 179–80.
   Google Scholar
• Eckhardt T, Heckers H. Treatment of human fasciolasis with niclofolan. Gastroenterology. 1981; 81: 795–8.
   Google Scholar
• Reshef R, Lok ASF, Sherlock S. Cholestatic jaundice in fasciolasis treated with niclofolan. Br Med J. 1982; 285: 1243–44.
   Google Scholar
• BorayJC, Crowfoot PB, Strong MB et al. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet Record. 1983; 113: 315–7.
   Google Scholar
• Coles GC. Anthelmintic activity of triclabendazole. J Helminthol. 1986; 60: 210–2.
   Google Scholar
• Le Bras M, Beylot J, Biessy H et al. Traitement de la fasciolase humaine par le triclabendazole. Med ChirDig. 1989; 18:477–9.
   Google Scholar
• Loutan L, Bouvier M, Rojanawisut B et al. Single treatment of invasive fasciolasis with triclabendazole. Lancet. 1989; ii: 383.
   Google Scholar
• Markwalder K, Roller M, Goebel N, Wolff K: Infektion mit Fasciola hepatica. Erfolgreiche Therapie mitTriclabendazol. SchweizMed Wschr. 1988; 118: 27–8.
   Google Scholar
• Wessely K, Reischig HL, Heinerman M, Stempka R. Human fasciolasis treated with triclabendazole (Fasinex) for the first time. Trans R Soc Trop Med Hyg. 1988; 82: 743–5.
   Google Scholar
• Poltera AA, Rouan MC. Triclabendazole et fasciolose humaine: les premiferes experiences. Bull Soc Fr Parasitol. 1990; 8 (suppl 1): 442.
   Google Scholar
• Schumacher-Rojanawisut B. Fasciolose humaine: nouveau traitement par le triclabendazole. Revue des methodes diagnostiques et tharapeutiques. Thfese 9189, Faculty de Medecine, University de Genfeve, Suisse, 1990.
   Google Scholar